Magnolia Neurosciences Corp, 430 E 29th St, Ste 840, New York, NY 10016, US

Kadmon Corporation, LLC is a New York-based company that focuses on developing innovative healthcare solutions. With a strong commitment to social impact, the company strives to improve access to healthcare, promote environmental sustainability, and foster diversity, equity, and inclusion. Kadmon Corporation's research and development efforts span various therapeutic areas, including immunology, neurology, oncology, rare blood disorders, rare diseases, and vaccines. Through scientific collaboration and clinical trials, the company aims to advance medical knowledge and bring new treatments to patients. Additionally, Kadmon Corporation is dedicated to responsible business practices and upholding its legacy of delivering impactful science. Kadmon Corporation's dedication to healthcare extends to its consumer healthcare division, which offers a range of products for allergy, cough, cold, flu, digestive wellness, pain care, and physical and mental wellness. The company also supports healthcare professionals through managed access programs and post-trial access initiatives. With a focus on partnering and innovation, Kadmon Corporation seeks collaborations in areas such as general medicines, immunology, neuroscience, oncology, rare diseases, and technology platforms. As a socially responsible company, Kadmon Corporation actively engages in environmental, social, and governance initiatives, and regularly communicates its financial results and investor events. With a global presence and a commitment to pushing boundaries, Kadmon Corporation is dedicated to improving the lives of patients and transforming healthcare.Generated from the website

Ann Judith Peterka, DO - Roche Trnsltnal-Clinical Research

Ratner, Adam J MD

Tara Biosystems

Times Square International Inc